Numeral (JSE:XII) Research & Development: R0.00 Mil (TTM As of Nov. 2025)


JSE:XII Numeral Ltd JSE:XII
10 GF Score
Price R0.33
! 5 Warning Signs
View Full Analysis

What is Numeral Research & Development?

Numeral JSE:XII 10 Research & Development is R0.00 Mil as of Nov. 2025. GuruFocus rates JSE:XII with a GF Score™ of 10/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Numeral's Research & Development for the three months ended in Nov. 2025 was R0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 was R0.00 Mil.

Numeral  (JSE:XII) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Numeral Research & Development Related Terms

Numeral Research & Development Historical Data

* Premium members only.

The historical data trend for Numeral's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numeral Research & Development Chart

Numeral Annual Data
Trend Dec14 Dec15 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Numeral Quarterly Data
Aug20 Nov20 Feb21 Aug21 Nov21 Feb22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
JSE:XII
10GF Score
Numeral Ltd JSE:XII
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Numeral Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was R0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R0.00 Mil mean?
Numeral (JSE:XII) has a Research & Development of R0.00 Mil as of Nov. 2025. Research and development expense is the total cost for research and development activities. View historical data on Numeral and its competitors.
Is Numeral's Research & Development too high?
Numeral's current Research & Development is R0.00 Mil. Overall, Numeral has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Numeral's Research & Development compare to ZTS and UTHR?
Numeral's Research & Development of R0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Numeral and its competitors. Numeral's current Research & Development is R0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numeral stock overvalued right now?
Numeral (JSE:XII) has a current Research & Development of R0.00 Mil. The current Research & Development is R0.00 Mil. Numeral's overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Numeral (JSE:XII), the current Research & Development is R0.00 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Numeral Business Description

Other Exchanges NXII.N0000:Mauritius
Address Sayed Hossen Road, Unit 13 Socota Phoenicia, Phoenix, MUS
Numeral Ltd is an investment holding company based in Mauritius with a focus on fintech, biotechnology, and asset management. Geographically it has a presence in countries across Africa, Europe and Asia. The majority of its revenue is generated in the form of Trading income.
10GF Score

Get the complete analysis for JSE:XII

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.33
Price